MISSISSAUGA, ON, May 29 /PRNewswire-FirstCall/ -- DRAXIS Pharma, the contract manufacturing division of DRAXIS Health Inc. (TSX: DAX) (NASDAQ:...
Targeted radiation therapy with DRAXIMAGE I-131 MIBG to be included in Phase I and Phase II trials coordinated with 13-member consortium of U.S...
First half results on track to meet guidance for 2005 MISSISSAUGA, ON, Aug. 11 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX; Nasdaq:...
Rx Communications Group Expands Canadian Presence With Addition of Two New Clients DRAXIS Health, Inc. and Theratechnologies Inc. Retain Rx...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.